Stock to Sell #6 –St.Jude Medical (STJ)
St. Jude Medical (NYSE:STJ), a maker of cardiovascular medical devices, struggles with earnings. In 2012, it is expected to earn $3.50 per share, up from $2.52, but it has a history of earnings disappointments and its chart is negative.
The stock failed to hold above its 200-day moving average in Q1, and its 20-day moving average broke its 50-day and 200-day moving averages. Distribution volume has been high and the stochastic recently issued a sell signal. The downside target for STJ is $33.